Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects.

Front Endocrinol (Lausanne) · 2020 · PMC7243137 · PMID 32499757

Europe PMC DOI

hedged sentence

0.1700

closest p · 3.4× alpha

0.1700

boldest claim

The sentences

did not reach statistical significancep = 0.17not close (p > 0.1)

Participants in the AI+WL group experienced greater weight reduction (−8.3 ± 7.5 kg) compared to PBO+WL group (−3.2 ± 3.8 kg) at 6 months of intervention; however, the difference did not reach statistical significance (adjusted p = 0.17) ( Figure 3A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.